Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002438:Cefoperazone; D002511:Cephalosporins / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D008802:Mezlocillin; D009369:Neoplasms / Q000382:microbiology*; D010406:Penicillins / Q000008:administration & dosage*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D002438:Cefoperazone; D008802:Mezlocillin